"The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternat"...
Synalgos-DC is contraindicated in patients with hypersensitivity to dihydrocodeine, codeine, or aspirin.
Last reviewed on RxList: 6/4/2013
This monograph has been modified to include the generic and brand name in many instances.
Additional Synalgos DC Information
Report Problems to the Food and Drug Administration
Chronic Pain/Back Pain
Find tips and advances in treatment.